Fierce Healthcare December 14, 2023
The Biden administration is cracking down on pharmaceutical companies as part of its price-fighting measures under the Inflation Reduction Act.
A dozen pharmaceutical companies will be required to pay rebates to Medicare for “outrageous price hikes” on prescription drugs that over 750,000 seniors take per year, White House officials said Thursday.
Centers for Medicare & Medicaid Services released a list of 48 prescription drugs that will have lower Part B beneficiary coinsurances in the first quarter of 2024, along with other updated guidance on Thursday.
“Starting in January, some Medicare beneficiaries who take these 48 prescription drugs – including drugs used to treat cancer and fight infections – will have lower coinsurance than what they would have paid otherwise, and...
Today's Sponsors
Today's Sponsor